ScoreWhy is Aspira Pathlab & Diagnostics Ltd ?
1
Healthy long term growth as Operating profit has grown by an annual rate 32.87%
2
With a growth in Net Profit of 85.86%, the company declared Outstanding results in Sep 25
- The company has declared positive results for the last 6 consecutive quarters
- OPERATING CF(Y) Highest at Rs 1.88 Cr
- NET SALES(9M) At Rs 19.12 cr has Grown at 30.60%
- ROCE(HY) Highest at 21.54%
3
With ROE of 23.6, it has a Very Attractive valuation with a 4.9 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -6.05%, its profits have risen by 368% ; the PEG ratio of the company is 0
4
Majority shareholders : Non Institution
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Aspira Pathlab should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Aspira Pathlab for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Aspira Pathlab
-8.31%
-0.12
51.40%
Sensex
4.32%
0.45
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.64%
EBIT Growth (5y)
32.87%
EBIT to Interest (avg)
1.47
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
1.07
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-5.51%
ROE (avg)
18.89%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
63
Price to Book Value
4.92
EV to EBIT
21.76
EV to EBITDA
14.90
EV to Capital Employed
4.61
EV to Sales
2.95
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
21.20%
ROE (Latest)
23.65%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend30What is working for the Company
OPERATING CF(Y)
Highest at Rs 1.88 Cr
NET SALES(9M)
At Rs 19.12 cr has Grown at 30.60%
ROCE(HY)
Highest at 21.54%
PAT(9M)
Higher at Rs 3.03 Cr
PBDIT(Q)
Highest at Rs 2.19 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 27.07%
PBT LESS OI(Q)
Highest at Rs 1.70 cr.
EPS(Q)
Highest at Rs 1.79
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Aspira Pathlab
Operating Cash Flow - Annually
Highest at Rs 1.88 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 8.09 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 8.09 cr has Grown at 30.91%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 2.19 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 27.07%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1.70 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 1.84 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 1.79
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
